Total planned funding: $213,147,377
Clear active filters
Rwanda
Private Contractor
2005
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Rwanda | $213,147,377 |
Organizational Types
| Private Contractor | $213,147,377 |
Program Areas
| Treatment | $136,998,986 |
| Governance and Systems | $33,843,656 |
| Care | $20,768,400 |
| Prevention | $9,409,617 |
| Testing | $8,685,280 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $115,037,478 |
| HLAB: Laboratory Infrastructure | $25,710,715 |
| HTXS: Treatment: Adult Treatment | $20,685,774 |
| HBHC: Care: Adult Care and Support | $13,641,802 |
| HVCT: Testing: HIV Testing and Counseling | $8,685,280 |
| HVSI: Strategic Information | $4,290,421 |
| OHSS: Health Systems Strengthening | $3,842,520 |
| HMIN: Biomedical Prevention: Injection Safety | $3,424,044 |
| PDCS: Care: Pediatric Care and Support | $3,367,401 |
| HVTB: Care: TB/HIV | $3,167,917 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $2,984,749 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $2,200,139 |
| PDTX: Treatment: Pediatric Treatment | $1,275,734 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $630,115 |
| HKID: Care: Orphans and Vulnerable Children | $591,280 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $170,570 |
| HMBL: Biomedical Prevention: Blood Safety | $0 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Chemonics International:
$71,340,101
Countries/Regions
John Snow, Inc:
$5,705,714
Countries/Regions
Voxiva:
$3,016,160
Countries/Regions